CD63 and neoplasm: The TIMP1/CD63/β1-integrin complex activates MAPK, FAK-PI3K, or YAP/TAZ signaling, which promotes cancer cell proliferation, growth, survival, migration, and EMT, regulates differentiation and inhibits apoptosis of cancer cells, ultimately leading to tumor progression and metastasis [63–70].